A Cross-Sectional Analysis of 2017-2022 National Immunization Survey: Sociodemographic Disparities Associated With Human Papillomavirus Vaccine Initiation and Completion Series Among US Adolescents
- PMID: 39487812
- PMCID: PMC11531671
- DOI: 10.1177/10732748241293674
A Cross-Sectional Analysis of 2017-2022 National Immunization Survey: Sociodemographic Disparities Associated With Human Papillomavirus Vaccine Initiation and Completion Series Among US Adolescents
Abstract
Objective: The introduction of the Human Papillomavirus (HPV) vaccine has led to future decline in prevalence of HPV-causing cancers; however, disparities in early HPV vaccine uptake and coverage may contribute to persistent inequalities in HPV-related cancers in the United States. We assess the current trend of sociodemographic factors significantly associated with the initiation and Up To Date (UTD) HPV vaccine series among adolescents in the U.S.
Methods: The retrospective National Immunization Survey-Teen data were analyzed for a cohort of adolescents aged 13-17 years who initiated HPV vaccine and completed the series from 2017 to 2022. A multivariable logistic regression estimated the correlation of sociodemographic variables to determine the odds of HPV vaccine initiation and completion as the outcomes.
Results: There were 3.2% and 5% surge in HPV vaccine initiation and UTD, respectively, with teens' mean age of 14.98 over the years. The unvaccinated dropped by 5.6%, and those not UTD declined by 4.6% in the HPV vaccine series during this period. The proportion of teens who initiated and completed the vaccine series were mostly older female teens, non-Hispanics, regularly insured with private coverage, raised by educated older mothers, above poverty status, and living in the South. The adjusted multivariable logistic regression shows the odds of initiating and completing increases over the years, and older teens are more likely to initiate the HPV vaccine and complete the vaccine series. However, boys with non-Medicaid coverage/uninsured in the South have lower odds to initiate and complete the vaccine.
Conclusion: Improved HPV vaccine uptake and UTD were found in older females, insured with Medicaid, and from highly educated mothers in the Northeast. Findings underscore the importance of effective strategies to address current HPV vaccination disparities among identified teens with lower uptake and UTD that may reduce future burden of HPV-related cancers in the U.S.
Keywords: cancer prevention; completion; human Papillomavirus vaccination; national immunization survey-TEEN; socio-demographic disparities; teen initiation.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States.BMC Public Health. 2017 Jul 14;18(1):19. doi: 10.1186/s12889-017-4567-2. BMC Public Health. 2017. PMID: 28709420 Free PMC article.
-
Rural-urban disparities in human papillomavirus vaccination: Findings from a cross-sectional survey of 13 southern US states, December 2019-January 2020.J Rural Health. 2025 Mar;41(2):e12913. doi: 10.1111/jrh.12913. J Rural Health. 2025. PMID: 40200105
-
Trends in Adolescent Human Papillomavirus Vaccination and Parental Hesitancy in the United States.J Infect Dis. 2023 Aug 31;228(5):615-626. doi: 10.1093/infdis/jiad055. J Infect Dis. 2023. PMID: 36869689 Free PMC article.
-
Human papillomavirus vaccine in adolescent women: a 2012 update.Curr Opin Obstet Gynecol. 2012 Oct;24(5):305-10. doi: 10.1097/GCO.0b013e3283567005. Curr Opin Obstet Gynecol. 2012. PMID: 22781077 Review.
-
Race, ethnicity and income as factors for HPV vaccine acceptance and use.Hum Vaccin Immunother. 2013 Jul;9(7):1413-20. doi: 10.4161/hv.24422. Epub 2013 Apr 9. Hum Vaccin Immunother. 2013. PMID: 23571170 Review.
References
-
- National Cancer Institute . HPV and cancer - NCI. Published March 1, 2019. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-ag.... Accessed January 27, 2024.
-
- How Many Cancers Are Linked with HPV Each Year? | CDC. Published September 13, 2023. Accessed January 27, 2024.https://www.cdc.gov/cancer/hpv/statistics/cases.htm
-
- American Joint Committee on Cancer . HPV-mediated (P16+) Oropharyngeal Cancer. Berlin: Springer; 2017. https://www.cancer.org/cancer/types/oral-cavity-and-oropharyngeal-cancer.... Accessed July 22, 2024.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources